bumetanide has been researched along with Fragile X Syndrome in 1 studies
Fragile X Syndrome: A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lemonnier, E | 1 |
| Robin, G | 1 |
| Degrez, C | 1 |
| Tyzio, R | 1 |
| Grandgeorge, M | 1 |
| Ben-Ari, Y | 1 |
1 other study available for bumetanide and Fragile X Syndrome
| Article | Year |
|---|---|
Treating Fragile X syndrome with the diuretic bumetanide: a case report.
Topics: Bumetanide; Child; Child Development Disorders, Pervasive; Diuretics; Fragile X Syndrome; Humans; Hy | 2013 |